Germany seeks collaboration on corona vaccine after US cash offer
Coronavirus chronicle
16 March, 2020, 01:25 pm
Last modified: 16 March, 2020, 01:30 pm
Employee Philipp Hoffmann, of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020/ Reuters
German officials today stressed that they favour a collaborative approach in the search for a vaccine against the novel coronavirus following reports that the US administration offered large sums to a German company working on a vaccine to make it available for exclusive use by the United States.
Citing German governent sources, Welt am Sonntag reported on March 15 that US President Donald Trump approached scientists employed by CureVac, a German pharmaceutical company based in Tuebingen, and tried to lure them to work for the US, Reuters reported.
More To Follow...
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.